Richard Christopher

Insider Reports History

Location
Rochester, NY
Signature
/Richard Christopher/
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Christopher:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lexaria Bioscience Corp. Chief Executive Officer, Director Stock Options 350K $427K $1.22 Jul 29, 2025 Direct
Lexaria Bioscience Corp. Chief Executive Officer, Director common shares 65K $59.1K $0.91 Jul 29, 2025 Direct
INVIVO THERAPEUTICS HOLDINGS CORP. Chief Financial Officer Stock Option (right to buy) 20.8K Nov 17, 2022 Direct

Insider Reports Filed by Richard Christopher

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LEXX Lexaria Bioscience Corp. Jul 29, 2025 1 $13.6K 4 Jul 30, 2025 Chief Executive Officer, Director
LEXX Lexaria Bioscience Corp. May 15, 2025 1 $0 4 May 16, 2025 Chief Executive Officer, Director
LEXX Lexaria Bioscience Corp. Dec 2, 2024 2 $118K 4 Dec 3, 2024 Chief Executive Officer
LEXX Lexaria Bioscience Corp. Aug 31, 2024 0 $0 3 Sep 5, 2024 Chief Executive Officer
NVIV INVIVO THERAPEUTICS HOLDINGS CORP. Nov 17, 2022 1 $0 4 Nov 21, 2022 Chief Financial Officer